BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25386164)

  • 1. Bariatric surgery and non-alcoholic Fatty liver disease: current and potential future treatments.
    Sasaki A; Nitta H; Otsuka K; Umemura A; Baba S; Obuchi T; Wakabayashi G
    Front Endocrinol (Lausanne); 2014; 5():164. PubMed ID: 25386164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review.
    Głuszyńska P; Lemancewicz D; Dzięcioł JB; Razak Hady H
    J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.
    Weiner RA
    Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: a future treatment by choice or by chance?
    Hafeez S; Ahmed MH
    J Obes; 2013; 2013():839275. PubMed ID: 23431426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.
    Nobili V; Vajro P; Dezsofi A; Fischler B; Hadzic N; Jahnel J; Lamireau T; McKiernan P; McLin V; Socha P; Tizzard S; Baumann U
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):550-61. PubMed ID: 25591123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects.
    Laursen TL; Hagemann CA; Wei C; Kazankov K; Thomsen KL; Knop FK; Grønbæk H
    World J Hepatol; 2019 Feb; 11(2):138-149. PubMed ID: 30820265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease: is bariatric surgery the answer?
    Pillai AA; Rinella ME
    Clin Liver Dis; 2009 Nov; 13(4):689-710. PubMed ID: 19818313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome.
    Aguilar-Olivos NE; Almeda-Valdes P; Aguilar-Salinas CA; Uribe M; Méndez-Sánchez N
    Metabolism; 2016 Aug; 65(8):1196-207. PubMed ID: 26435078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease from pathogenesis to management: an update.
    Musso G; Gambino R; Cassader M
    Obes Rev; 2010 Jun; 11(6):430-45. PubMed ID: 19845871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Metabolic Surgery in Non-alcoholic Steatohepatitis Improvement.
    Caravatto PP; Cohen R
    Curr Atheroscler Rep; 2017 Oct; 19(11):45. PubMed ID: 28986720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.
    Qureshi K; Abrams GA
    Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with clinically metabolically healthy obesity are not necessarily healthy subclinically: further support for bariatric surgery in patients without metabolic disease?
    Haskins IN; Chang J; Nor Hanipah Z; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Obes Relat Dis; 2018 Mar; 14(3):342-346. PubMed ID: 29519663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Considerations for bariatric surgery in patients with cirrhosis.
    Goh GB; Schauer PR; McCullough AJ
    World J Gastroenterol; 2018 Jul; 24(28):3112-3119. PubMed ID: 30065557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bariatric Surgery in NAFLD.
    Chauhan M; Singh K; Thuluvath PJ
    Dig Dis Sci; 2022 Feb; 67(2):408-422. PubMed ID: 34981313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets.
    Younossi ZM; Reyes MJ; Mishra A; Mehta R; Henry L
    Aliment Pharmacol Ther; 2014 Jan; 39(1):3-14. PubMed ID: 24206433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC; Berk PD
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.